Crinetics Pharmaceuticals, Inc. (CRNX) Sentiment
30-day SentiSense Score 1.04 · Neutral · ▲ warming · as of 2026-09-23
CRNX sentiment is neutral (30-day SentiSense Score 1) and strengthening from a month ago; there is no reading for today yet. Attention averages ~6 mentions/day (1 today).
- Sentiment (30-day)
- Neutral
- SentiSense Score (30-day avg)
- 1.04
- Mentions / day (30-day avg)
- 6 (1 today)
Where the conversation is happening
- News
- Bullish · 60% of mentions
- X
- Bullish · 28% of mentions
- Neutral · 12% of mentions
Related tickers
What's driving it
- Vertex Q2 Revenue Beats, Adjusted EPS Narrowly Misses, FY26 Revenue Guidance Raised (+0.48)
- Vertex Pharmaceuticals Acquires Crinetics Pharmaceuticals for $10B (+0.84)
- Pharma Companies Report Promising Phase 2 Trial Results (+0.78)
Live SentiSense Score, sentiment history, and per-source breakdown for Crinetics Pharmaceuticals, Inc. on SentiSense.
See how CRNX's sector compares in the market sentiment heatmap